Skip to main content
Top
Published in: BMC Infectious Diseases 1/2011

Open Access 01-12-2011 | Correspondence

Ebola haemorrhagic fever outbreak in Masindi District, Uganda: outbreak description and lessons learned

Authors: Matthias Borchert, Imaam Mutyaba, Maria D Van Kerkhove, Julius Lutwama, Henry Luwaga, Geoffrey Bisoborwa, John Turyagaruka, Patricia Pirard, Nestor Ndayimirije, Paul Roddy, Patrick Van Der Stuyft

Published in: BMC Infectious Diseases | Issue 1/2011

Login to get access

Abstract

Background

Ebola haemorrhagic fever (EHF) is infamous for its high case-fatality proportion (CFP) and the ease with which it spreads among contacts of the diseased. We describe the course of the EHF outbreak in Masindi, Uganda, in the year 2000, and report on response activities.

Methods

We analysed surveillance records, hospital statistics, and our own observations during response activities. We used Fisher's exact tests for differences in proportions, t-tests for differences in means, and logistic regression for multivariable analysis.

Results

The response to the outbreak consisted of surveillance, case management, logistics and public mobilisation. Twenty-six EHF cases (24 laboratory confirmed, two probable) occurred between October 21st and December 22nd, 2000. CFP was 69% (18/26). Nosocomial transmission to the index case occurred in Lacor hospital in Gulu, outside the Ebola ward. After returning home to Masindi district the index case became the origin of a transmission chain within her own extended family (18 further cases), from index family members to health care workers (HCWs, 6 cases), and from HCWs to their household contacts (1 case). Five out of six occupational cases of EHF in HCWs occurred after the introduction of barrier nursing, probably due to breaches of barrier nursing principles. CFP was initially very high (76%) but decreased (20%) due to better case management after reinforcing the response team. The mobilisation of the community for the response efforts was challenging at the beginning, when fear, panic and mistrust had to be countered by the response team.

Conclusions

Large scale transmission in the community beyond the index family was prevented by early case identification and isolation as well as quarantine imposed by the community. The high number of occupational EHF after implementing barrier nursing points at the need to strengthen training and supervision of local HCWs. The difference in CFP before and after reinforcing the response team together with observations on the ward suggest a critical role for intensive supportive treatment. Collecting high quality clinical data is a priority for future outbreaks in order to identify the best possible FHF treatment regime under field conditions.
Appendix
Available only for authorised users
Literature
1.
go back to reference WHO/International Study Team: Ebola haemorrhagic fever in Sudan, 1976. Bull World Health Organ. 1978, 56 (2): 247-270. WHO/International Study Team: Ebola haemorrhagic fever in Sudan, 1976. Bull World Health Organ. 1978, 56 (2): 247-270.
2.
go back to reference Baron RC, McCormick JB, Zubeir OA: Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread. Bull World Health Organ. 1983, 61 (6): 997-1003.PubMedPubMedCentral Baron RC, McCormick JB, Zubeir OA: Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread. Bull World Health Organ. 1983, 61 (6): 997-1003.PubMedPubMedCentral
3.
go back to reference WHO: Outbreak of Ebola haemorrhagic fever, Uganda, August 2000-January 2001. Wkly Epidemiol Rec. 2001, 76 (6): 41-46. WHO: Outbreak of Ebola haemorrhagic fever, Uganda, August 2000-January 2001. Wkly Epidemiol Rec. 2001, 76 (6): 41-46.
4.
go back to reference Okware SI, Omaswa FG, Zaramba S, Opio A, Lutwama JJ, Kamugisha J, Rwaguma EB, Kagwa P, Lamunu M: An outbreak of Ebola in Uganda. Trop Med Int Health. 2002, 7 (12): 1068-1075. 10.1046/j.1365-3156.2002.00944.x.CrossRefPubMed Okware SI, Omaswa FG, Zaramba S, Opio A, Lutwama JJ, Kamugisha J, Rwaguma EB, Kagwa P, Lamunu M: An outbreak of Ebola in Uganda. Trop Med Int Health. 2002, 7 (12): 1068-1075. 10.1046/j.1365-3156.2002.00944.x.CrossRefPubMed
5.
go back to reference Lamunu M, Lutwama JJ, Kamugisha J, Opio A, Nambooze J, Ndayimirije N, Okware S: Containing a haemorrhagic fever epidemic: the Ebola experience in Uganda (October 2000 - January 2001). Int J Infect Dis. 2004, 8: 27-37. 10.1016/j.ijid.2003.04.001.CrossRefPubMed Lamunu M, Lutwama JJ, Kamugisha J, Opio A, Nambooze J, Ndayimirije N, Okware S: Containing a haemorrhagic fever epidemic: the Ebola experience in Uganda (October 2000 - January 2001). Int J Infect Dis. 2004, 8: 27-37. 10.1016/j.ijid.2003.04.001.CrossRefPubMed
6.
go back to reference WHO: Outbreak of Ebola haemorrhagic fever in Yambio, south Sudan, April-June 2004. Wkly Epidemiol Rec. 2005, 80 (43): 370-375. WHO: Outbreak of Ebola haemorrhagic fever in Yambio, south Sudan, April-June 2004. Wkly Epidemiol Rec. 2005, 80 (43): 370-375.
7.
go back to reference WHO: Ebola, Uganda (update). Wkly Epidemiol Rec. 2001, 76 (1): 1-1. WHO: Ebola, Uganda (update). Wkly Epidemiol Rec. 2001, 76 (1): 1-1.
8.
go back to reference Bitekyerezo M, Kyobutungi C, Kizza R, Mugeni J, Munyarugero E, Tirwomwe F, Twongyeirwe E, Muhindo G, Nakibuuka V, Nakate M, et al: The outbreak and control of Ebola viral haemorrhagic fever in a Ugandan medical school. Trop Doct. 2002, 32: 10-15.PubMed Bitekyerezo M, Kyobutungi C, Kizza R, Mugeni J, Munyarugero E, Tirwomwe F, Twongyeirwe E, Muhindo G, Nakibuuka V, Nakate M, et al: The outbreak and control of Ebola viral haemorrhagic fever in a Ugandan medical school. Trop Doct. 2002, 32: 10-15.PubMed
9.
go back to reference WHO: Ebola, Uganda (update). Wkly Epidemiol Rec. 2001, 76 (4): 25-25. WHO: Ebola, Uganda (update). Wkly Epidemiol Rec. 2001, 76 (4): 25-25.
10.
go back to reference Sanchez A, Lukwiya M, Bausch D, Mahanty S, Sanchez AJ, Wagoner KD, Rollin PE: Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels. J Virol. 2004, 78 (19): 10370-10377. 10.1128/JVI.78.19.10370-10377.2004.CrossRefPubMedPubMedCentral Sanchez A, Lukwiya M, Bausch D, Mahanty S, Sanchez AJ, Wagoner KD, Rollin PE: Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels. J Virol. 2004, 78 (19): 10370-10377. 10.1128/JVI.78.19.10370-10377.2004.CrossRefPubMedPubMedCentral
11.
go back to reference Rollin PE, Bausch DG, Sanchez A: Blood chemistry measurements and D-Dimer levels associated with fatal and nonfatal outcomes in humans infected with Sudan Ebola virus. J Infect Dis. 2007, 196: S364-S371. 10.1086/520613.CrossRefPubMed Rollin PE, Bausch DG, Sanchez A: Blood chemistry measurements and D-Dimer levels associated with fatal and nonfatal outcomes in humans infected with Sudan Ebola virus. J Infect Dis. 2007, 196: S364-S371. 10.1086/520613.CrossRefPubMed
12.
go back to reference WHO, CDC: Infection Control for Viral Haemorrhagic Fevers in the African Health Care Setting. 1998, Geneva, Switzerland: WHO, 1 WHO, CDC: Infection Control for Viral Haemorrhagic Fevers in the African Health Care Setting. 1998, Geneva, Switzerland: WHO, 1
13.
go back to reference WHO: Outbreak(s) of Ebola haemorrhagic fever in the Republic of the Congo, January-April 2003. Wkly Epidemiol Rec. 2003, 78 (33): 285-289. WHO: Outbreak(s) of Ebola haemorrhagic fever in the Republic of the Congo, January-April 2003. Wkly Epidemiol Rec. 2003, 78 (33): 285-289.
14.
go back to reference Roddy P, Weatherill D, Jeffs B, Abaakouk Z, Dorion C, Rodriguez-Martinez P, Palma PP, de La Rosa O, Villa L, Grovas I, et al: The Médecins Sans Frontières intervention in the Marburg epidemic, Uige/Angola, 2005. II. Lessons learned in the community. J Infect Dis. 2007, 196 (Suppl 2): S162-S167.CrossRefPubMed Roddy P, Weatherill D, Jeffs B, Abaakouk Z, Dorion C, Rodriguez-Martinez P, Palma PP, de La Rosa O, Villa L, Grovas I, et al: The Médecins Sans Frontières intervention in the Marburg epidemic, Uige/Angola, 2005. II. Lessons learned in the community. J Infect Dis. 2007, 196 (Suppl 2): S162-S167.CrossRefPubMed
15.
go back to reference Dowell SF: Ebola haemorrhagic fever: why were children spared?. Pediatr Infect Dis J. 1996, 15 (3): 189-191. 10.1097/00006454-199603000-00002.CrossRefPubMed Dowell SF: Ebola haemorrhagic fever: why were children spared?. Pediatr Infect Dis J. 1996, 15 (3): 189-191. 10.1097/00006454-199603000-00002.CrossRefPubMed
16.
go back to reference Dowell SF, Mukunu R, Ksiazek TG, Khan AS, Rollin PE, Peters CJ, the Commisson de Lutte contre les Epidémies à Kikwit: Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis. 1999, 179 (Suppl 1): S87-S91.CrossRefPubMed Dowell SF, Mukunu R, Ksiazek TG, Khan AS, Rollin PE, Peters CJ, the Commisson de Lutte contre les Epidémies à Kikwit: Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis. 1999, 179 (Suppl 1): S87-S91.CrossRefPubMed
17.
go back to reference Mupere E, Kaducu OF, Yoti Z: Ebola haemorrhagic fever among hospitalised children and adolescents in northern Uganda: epidemiologic and clinical observations. Afr Health Sci. 2001, 1 (2): 60-65.PubMedPubMedCentral Mupere E, Kaducu OF, Yoti Z: Ebola haemorrhagic fever among hospitalised children and adolescents in northern Uganda: epidemiologic and clinical observations. Afr Health Sci. 2001, 1 (2): 60-65.PubMedPubMedCentral
19.
go back to reference Jeffs B, Roddy P, Weatherill D, De La Rosa O, Dorion C, Iscla M, Grovas I, Palma PP, Villa L, Bernal O, et al: The Médecins Sans Frontières intervention in the Marburg epidemic, Uige/Angola, 2005. I. Lessons learned in the hospital. J Infect Dis. 2007, 196 (Suppl 2): S154-S161.CrossRefPubMed Jeffs B, Roddy P, Weatherill D, De La Rosa O, Dorion C, Iscla M, Grovas I, Palma PP, Villa L, Bernal O, et al: The Médecins Sans Frontières intervention in the Marburg epidemic, Uige/Angola, 2005. I. Lessons learned in the hospital. J Infect Dis. 2007, 196 (Suppl 2): S154-S161.CrossRefPubMed
20.
go back to reference Towner JS, Khristova ML, Sealy TK, Vincent MJ, Erickson BR, Bawiec DA, Hartman AL, Comer JA, Zaki SR, Ströher U, et al: Marburgvirus genomics and association with a large hemorrhagic fever outbreak in Angola. J Virol. 2006, 80 (13): 6497-6516. 10.1128/JVI.00069-06.CrossRefPubMedPubMedCentral Towner JS, Khristova ML, Sealy TK, Vincent MJ, Erickson BR, Bawiec DA, Hartman AL, Comer JA, Zaki SR, Ströher U, et al: Marburgvirus genomics and association with a large hemorrhagic fever outbreak in Angola. J Virol. 2006, 80 (13): 6497-6516. 10.1128/JVI.00069-06.CrossRefPubMedPubMedCentral
21.
go back to reference Bausch DG, Towner JS, Dowell SF, Kaducu F, Lukwiya M, Sanchez A, Nichol ST, Ksiazek TG, Rollin PE: Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis. 2007, 196: S142-S147. 10.1086/520545.CrossRefPubMed Bausch DG, Towner JS, Dowell SF, Kaducu F, Lukwiya M, Sanchez A, Nichol ST, Ksiazek TG, Rollin PE: Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis. 2007, 196: S142-S147. 10.1086/520545.CrossRefPubMed
22.
go back to reference Colebunders R, Tshomba A, Van Kerkhove M, Bausch DG, Campbell P, Libande M, Pirard P, Tshioko F, Mardel S, Mulangu S, et al: Marburg hemorrhagic fever in Durba and Watsa, Democratic Republic of the Congo: clinical documentation, features of illness, and treatment. J Infect Dis. 2007, 196 (Suppl 2): S148-S153.CrossRefPubMed Colebunders R, Tshomba A, Van Kerkhove M, Bausch DG, Campbell P, Libande M, Pirard P, Tshioko F, Mardel S, Mulangu S, et al: Marburg hemorrhagic fever in Durba and Watsa, Democratic Republic of the Congo: clinical documentation, features of illness, and treatment. J Infect Dis. 2007, 196 (Suppl 2): S148-S153.CrossRefPubMed
Metadata
Title
Ebola haemorrhagic fever outbreak in Masindi District, Uganda: outbreak description and lessons learned
Authors
Matthias Borchert
Imaam Mutyaba
Maria D Van Kerkhove
Julius Lutwama
Henry Luwaga
Geoffrey Bisoborwa
John Turyagaruka
Patricia Pirard
Nestor Ndayimirije
Paul Roddy
Patrick Van Der Stuyft
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2011
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-11-357

Other articles of this Issue 1/2011

BMC Infectious Diseases 1/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.